Fennec Pharmaceuticals Inc banner
F

Fennec Pharmaceuticals Inc
TSX:FRX

Watchlist Manager
Fennec Pharmaceuticals Inc
TSX:FRX
Watchlist
Price: 9.81 CAD Market Closed
Market Cap: CA$268m

Wall St Price Targets

FRX Price Targets Summary
Fennec Pharmaceuticals Inc

Wall Street analysts forecast FRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FRX is 20.72 CAD with a low forecast of 17.59 CAD and a high forecast of 25.32 CAD.

Lowest Forecast
Price Target
17.59 CAD
79% Upside
Average Forecast
Price Target
20.72 CAD
111% Upside
Highest Forecast
Price Target
25.32 CAD
158% Upside
Fennec Pharmaceuticals Inc Competitors:
Price Targets
VAC
Pierre et Vacances SA
21% Upside
AYTU
Aytu Biopharma Inc
281% Upside
EXPO
Exponent Inc
45% Upside
CENT
Central Garden & Pet Co
29% Upside
ELAN
Elanco Animal Health Inc
28% Upside
NYXH
Nyxoah SA
222% Upside
PTGX
Protagonist Therapeutics Inc
17% Upside

Revenue
Forecast

N/A
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

The compound annual growth rate for Revenue over the next 8 years is 22%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is FRX's stock price target?
Price Target
20.72 CAD

According to Wall Street analysts, the average 1-year price target for FRX is 20.72 CAD with a low forecast of 17.59 CAD and a high forecast of 25.32 CAD.

What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
22%

The compound annual growth rate for Revenue over the next 8 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett